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To the Editor: Gnathostomiasis 
is an infestation by nematodes of 
the genus Gnathostoma; the main 
source of infection is raw freshwater 
fi sh. In the past, gnathostomiasis was 
regarded as restricted to certain Asian 
and Central American countries, but 
increase of migratory fl ux and changes 
in alimentary habits have contributed 
to importing cases into areas where 
the disease is not endemic (1,2). 
We report a case of autochthonous 
gnasthostomiasis in Brazil.
A 37-year-old man from Rio de 
Janeiro sought medical attention in 
2005 because of low fever, cough, 
abdominal tenderness, and pain in 
the left shoulder. The symptoms 
started 15 days after a recreational 
trip to Tocantins, where he practiced 
sport fi shing and ate sashimi-
style freshwater raw fi sh (Cichla 
sp.) that had just been caught. He 
reported no history of traveling to a 
gnathostomiasis-endemic area. Initial 
work-up depicted eosinophilia (43%), 
and a computed tomographic scan of 
the chest revealed left pleural effusion. 
Two weeks later, winding, linear, 
reddish lesions appeared on his back, 
which lasted 3 days (Figure, panel 
A). Serologic testing for Schistosoma 
mansoni was weakly positive. Acute 
schistosomiasis was diagnosed, and 
treatment with praziquantel was 
begun. In 4 weeks, all symptoms 
faded.
In 2009, the patient took 
albendazol for helminthic 
prophylaxis, and 3 weeks later, deep 
migratory, swelling, reddish nodules 
occurred on the thorax; each lesion 
lasted ≈6 days, and new lesions 
appeared at intervals of 1–5 days 
in a somewhat linear array (Figure, 
panel B). By this time, hemograms 
displayed eosinophilia of 25%, but 
a computed tomographic scan of 
the chest showed no abnormalities. 
Results of a complete ophthalmologic 
examination were unremarkable, and 
a fecal examination was negative 
for parasites. Gnathostomiasis 
was highly suspected on the basis 
of the clinical and epidemiologic 
fi ndings and results of skin biopsies. 
Histopathologic examination re-
vealed a dense superfi cial and deep 
dermal infi ltrate of eosinophils and 
neutrophils but did not show the 
parasite. Two samples of plasma were 
sent to Thailand for immunoblot in 
search of the diagnostic band (24-kDa 
antigen) of Gnathostoma spinigerum, 
resulting in high titers. Albendazol, 
800 mg/day for 21 days, and a 
single dose of ivermectin, 0.2 mg/
kg, were administered and, despite 
initial improvement, the disease 
relapsed, requiring a second cycle of 
the medications. No signs of disease 
occurred during 2 years of follow-up.
Gnathostomiasis is found 
mostly in Japan and Thailand. In the 
Americas, most cases occur in Mexico 
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(3). Gnathostomiasis was previously 
reported in Brazil, but the patient was 
infected in Peru (4).
Four species are known to cause 
disease in humans, and G. spinigerum 
is the most frequent cause. Adult 
parasites live in the stomach of 
defi nitive hosts (dogs, cats, and other 
fi sh-eating mammals), and eggs are 
eliminated in feces. These hatch and 
release the fi rst-stage larvae in fresh 
water; larvae are ingested by the fi rst 
intermediate host, a copepod, and 
develop into second-stage larvae. 
Copepods are ingested by the second 
intermediate hosts (fi sh, eels, frogs, 
birds, and reptiles), and larvae mature 
to the third stage. When eaten by an 
appropriate defi nitive host, third-stage 
larvae evolve to adults and fi nally 
reach the stomach of their host.
Third-stage larvae cannot mature 
in humans and keep migrating in skin, 
subcutaneous tissue, or other organs. 
Initial signs and symptoms are fever, 
anorexia, nausea, vomiting, diarrhea, 
malaise, urticaria, and epigastric 
pain. Eosinophilia is frequent. After 
2–4 weeks, larvae migrate to skin or 
subcutaneous tissue, causing winding 
linear erythematous lesions or 
migratory swelling nodules. Cutaneous 
gnathostomiasis is the most common 
form of disease. The larvae also can 
migrate to lungs; genitourinary tract; 
digestive tract; ears; eyes; and rarely, 
the central nervous system, which may 
result in death (5). If left untreated, 
gnathostomiasis may remit and recur 
several times until death of the larvae 
≈12 years after infection.
The rate of detection of larvae 
in skin biopsy specimens varies 
from 24% to 34%, and the diagnosis 
frequently needs confi rmation by 
serologic testing (3). Immunoblot is 
highly sensitive and specifi c and is 
regarded as the most valuable ancillary 
technique (1,6). The diagnosis in the 
patient reported here had a 4-year 
delay, despite investigation in several 
renowned institutions.
The treatment of choice is 
albendazol, 800 mg/day for 21 
days, but ivermectin, 0.2 mg/kg in a 
single dose or for 2 subsequent days, 
is an alternative (7). More than 1 
treatment cycle might be required 
(8). Albendazole promotes outward 
migration of the larvae to the dermis, 
and we believe that the low doses used 
for helminths by the patient reported 
here might have activated quiescent 
larvae and triggered new lesions (9).
A high index of suspicion is 
necessary to diagnose this disease 
in areas where it is not endemic. 
Gnathostomiasis must be suspected 
in a patient who has a history of 
eating raw freshwater fi sh, persistent 
eosinophilia, and larva migrans–like 
lesions and/or migratory deep nodules 
in a linear array. History of traveling to 
gnathostomiasis-endemic areas is not 
strictly necessary, considering recent 
reports of gnathostomiasis acquisition 
in previously unaffected regions (10).
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Figure. Gnathostomiasis in a 37-year-old man, Brazil. A) Evanescent winding, linear, reddish lesions on the back in 2005. B) Deep 
migratory reddish nodules (arrows) on the lateral thorax, occurring in 2009 after treatment with albendazol for helmintic prophylaxis.
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To the Editor: The Ixodes ricinus 
tick is a predominant vector of a large 
variety of pathogens of veterinary and 
medical consequence in Europe (1). 
The most prevalent I. ricinus–borne 
infection of persons in Europe is Lyme 
borreliosis, a multisystemic disorder 
caused by spirochetes of the Borrelia 
burgdorferi sensu lato complex (2). 
Persons bitten by ticks can also become 
infected with many other pathogens, 
such as bacteria (Anaplasma spp., 
Francisella spp., Coxiella burnetii, 
Bartonella spp., Rickettsiae spp., and 
Neoerhlichia mikurensis); parasites 
(Babesia spp., Theileria spp.); and 
arboviruses (tick-borne encephalitis 
virus, Crimean-Congo hemorrhagic 
fever virus, and Eyach virus) (1). 
Symptoms induced by such pathogens 
are often diverse and nonspecifi c, 
complicating accurate diagnosis of the 
disease.
In Romania, cases of Lyme 
disease and tick-borne encephalitis 
(caused by tick-borne encephalitis 
virus) have been identifi ed (3). 
However, little is known about the 
public health impact of these diseases, 
and none of the other tick-borne 
pathogens present in Europe have 
been reported as causes of infection 
in Romania. Although I. ricinus is the 
most abundant and widespread tick in 
Romania (3), the public health impact 
of I. ricinus–borne disease is likely 
to be underestimated. Therefore, the 
fi rst step in evaluating the distribution 
of these potential pathogens is to 
establish their presence in ticks from 
previously unexplored areas.
We conducted a study to identify 
the main tick-borne bacterial and 
parasitic human pathogens known 
to be present in Europe but not 
previously detected in Romania. 
 We tested for the presence of DNA 
from spotted fever group Rickettsia 
spp., Anaplasma spp., Francisella 
tularensis, and Babesia spp. in 147 I. 
ricinus ticks collected from roe deer 
and goats at 2 sites in eastern Romania: 
Bacau (46°35′0″N, 26°55′0″E) and 
Galati (45°26′22″N, 28°2′4″E). 
Specimens were tested by PCR, using 
specifi c primers for each pathogen or 
group of pathogens, as described (4). 
Sequences obtained from Eurofi ns 
MWG Operon (Ebersberg, Germany) 
were identifi ed by using BLAST 
(www.ncbi.nlm.nih.gov/BLAST) and 
compared with sequences available 
in GenBank. 
DNA from Rickettsia spp. was 
detected in 20 (13.6%) ticks. Sequence 
analyses revealed that 9 (6.1%) 
sequences were related to the R. 
monacensis strain IRd/Serbia glta gene 
(99%–100% nt similarity) (GenBank 
accession no. GQ925820) and 11 
(7.48%) were related to R. helvetica 
gltA gene (99%–100% nt similarity) 
(GenBank accession no. AM418450). 
DNA from Anaplasma spp. was 
identifi ed in 33 (22.4%) ticks. Analysis 
revealed that 30 of the 33 amplifi ed 
fragments showed 100% identity to 
the 16S rDNA gene of a symbiont 
in the family Anaplasmataceae, 
Candidatus Midichloria mitochondrii 
(GenBank accession no. EU780455), 
and the remaining 3 were related to 
known pathogenic species identifi ed 
in Romania: 2 (1.4%) exhibited 
100% identity to Anaplasma 
phagocytophilum (GenBank accession 
no. EU982548), and 1 (0.7%) showed 
99% similarity to Ehrlichia muris 
(GenBank accession no. GU358691). 
Francisella tularensis–specifi c DNA 
was amplifi ed from 4 DNA extracts 
(2.7%). All 4 sequences were identical 
and shared 99% similarity with the F. 
tularensis peptidyl-propyl cis-trans 
isomerase gene (GenBank accession 
no. CP003048). Babesia spp.–specifi c 
DNA was amplifi ed in 1 DNA extract 
(0.7%), and it shared 99% sequence 
identity with the Babesia sp. EU1 18S 
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